Article Text

Download PDFPDF

#167 SLN – mapping in endometrial cancer using IMAGE1 S™ rubina – K. STORZ (ICG/NIR technology)
Free
  1. Andreas Kavallaris,
  2. Dimitrios Zygouris,
  3. Ourania Kaiafa,
  4. Panagiotis Papandreou,
  5. Sofia Papadimitriou,
  6. Evgenia Stergiannakou and
  7. Antonios Gkoutzioulis
  1. St. lukes Hospital, Thessaloniki, Greece

Abstract

Introduction/Background The sentinel lymph node (SLN) mapping may have particular value in endometrial cancer (EC) because a therapeutic effect of lymphadenectomy per se is still unproven.

Methodology From March 2017 through December 2022, 114 women with apparently early stage EC underwent laparoscopic hysterectomy including ICG fluorescence SLN mapping. In all of the cases we use the IMAGE1 S™ Rubina – K. STORZ.

Results In all patients more than ≥1 SLNs was identified. In 94 (84.2%) patients bilaterally and in 20 (14.8%) patients unilaterally. All SLN-positive patients had pelvic SLNs. Lymph node metastases were detected in 6 patients (5.2%).

Conclusion With the standardization of the technique we managed to reproduce the high total and bilateral SLN mapping using cervical ICG injection and NIR fluorescence.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.